PsyAccess
Am I eligible?
Am I eligible?
Spravato®Registry-verifiedDesignated-centers model

Klinik Arlesheim

Arlesheim, Switzerland

Treatment & access

  • Treatments offeredEsketamine nasal spray (Spravato®)
  • Access routeCovered by a national programme
  • Cost & coverage (registry status)Reimbursed by mandatory health insurance (OKP/AOS) per SL Limitatio
  • ReimbursementBAG Spezialitätenliste Limitatio: cantonal psychiatric care mandate required; list valid 2025-10-01 to 2028-09-30 How reimbursement works in Europe →
  • Phone+41 61 705 71 11
  • Websitehttps://www.klinik-arlesheim.ch

About this provider

Klinik Arlesheim is an acute hospital for anthroposophic medicine in Arlesheim (canton Basel-Landschaft) whose psychiatry and psychosomatics unit treats adults from age 18 in outpatient consultations and on two open inpatient wards (general psychiatry and psychosomatics). Treatment is based on conventional medicine, extended by integrative anthroposophic psychiatry, milieu-therapeutic ward concepts, integrative nursing and artistic therapies. Its public pages do not describe a dedicated esketamine programme, so ask the psychiatry secretariat how Spravato treatment is arranged.

Services & programs

  • Outpatient psychiatric consultations
  • Inpatient psychiatry ward (open, general psychiatric)
  • Inpatient psychosomatics ward
  • Biography work and group therapy offers
  • Artistic therapies (eurythmy therapy, painting, music, therapeutic speech)
  • Physiotherapy
  • Anthroposophic nursing

Common questions

How do I get admitted for depression treatment at Klinik Arlesheim?

For inpatient treatment the clinic requires referral by a family doctor or psychiatrist, followed by a clarification consultation that is part of the treatment; outpatient appointments are booked via the psychiatry/psychosomatics secretariat (+41 61 705 72 81).

What are the Swiss insurance conditions for Spravato?

Under the BAG Limitatio, basic insurance covers esketamine nasal spray for adults 18-74 with treatment-resistant depression (at least two antidepressants with different mechanisms plus one augmentation attempt failed, confirmed severity) only after the insurer's cost approval (Kostengutsprache) is granted before the first dose, for a maximum of 10 months.

Looking at alternatives? One of the BAG-designated Spravato centers in Switzerland; see the country guide and the limited-medical-use PAT program.

37 more verified providers within 50 km

See them on the provider map →

Verification

At least one source for this record is a public state registry or an official public-law register. The registry entry is linked below and re-checked at least every 90 days.

Spotted an error? See our methodology for how records are checked and how to report a correction.

Check your fit & enquire

Spravato® access in Switzerland follows published criteria. A short pre-screening comes first, then your compiled summary goes to Klinik Arlesheim only with your explicit consent, and you can download it for yourself either way.

Why enquire via PsyAccess

  • Pre-screening first. A 2-minute check in your browser shows which legal routes fit your situation, before you reach out to anyone.
  • A structured enquiry. Your enquiry reaches the provider with a structured summary, so the clinic can reply quickly and to the point.
  • Independent & free. Free for patients. We don't charge for enquiries, and no provider pays for placement.
Check my fit & enquire

About two minutes. The check itself runs in your browser: your answers are never sent anywhere unless you choose to send them. We count only anonymous usage events.

Check my fit & enquire